SARS-CoV-2 specific monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SARS-CoV-2 specific monoclonal antibody, covering 2025-08-05 to 2025-08-05. Get the full timeline:
Most recent: Clinical Trial Update: SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID) [Phase 2]